Key result
The clinical utility of quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes for diagnosing deep venous thrombosis could not be determined as no data was provided.
Why the study?
Do ELISA assays for TAT, FbDP, FgDP, and TDP accurately diagnose deep venous thrombosis in outpatients?
Population
239 consecutive outpatients suspected for deep venous thrombosis by their family doctor, and 42 healthy…
Comparison
ELISA assays for thrombin-antithrombin III… vs Impedance plethysmography.
Design
Cross-sectional
Authors
Loading...
Data insufficient to assess ELISA utility for DVT; leaves open need for complete diagnostic accuracy studies.
Do ELISA assays for TAT, FbDP, FgDP, and TDP accurately diagnose deep venous thrombosis in outpatients?
Quantitative determination of TAT, FbDP, FgDP, and TDP by ELISA is of little value for diagnosing DVT in outpatients due to inadequate sensitivity and specificity.
Bergen et al. (1989) studied Deep Venous Thrombosis. Quantitative Determination of Fibrin(ogen) Degradation Products and Thrombin-Antithrombin III Complexes was evaluated. The clinical utility of quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes for diagnosing deep venous thrombosis could not be determined as no data was provided.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: